Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Background: The aim of this study is to assess the survival benefits of additional induction chemotherapy before concurrent chemotherapy, intensity-modulated radiotherapy and nimotuzumab in patients with locoregionally advanced nasopharyngeal carcinoma. Methods: Clinical data from 1104 nonmetastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fangzheng, Sun, Quanquan, Jiang, Chuner, Liu, Tongxin, Rihito, Aizawa, Masoto, Sakamoto, Wang, Yuezhen, Fu, Zhenfu, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820927/
https://www.ncbi.nlm.nih.gov/pubmed/29483965
http://dx.doi.org/10.7150/jca.20461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820927/
https://www.ncbi.nlm.nih.gov/pubmed/29483965
http://dx.doi.org/10.7150/jca.20461

Ejemplares similares